Integrative Research Institute
Sacramento, California, 95819, United States
Location status: Recruiting
NCT Number: NCT07544251
This study is being done to help better understand how the gut and skin bacteria of the body change when people with acne are treated with Sarecycline or Doxycycline. The bacteria in the gut and on the skin will be studied to see how each treatment may affect them and whether they change the profile of the bacteria that is present.
Interested in participating?
Request Info9 year and older
All sexes
Interventional
Phase 4
Sacramento, California, 95819, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2a) Within 2 week prior to randomization:
2b) Within 4 weeks prior to randomization:
2c) Within 12 weeks prior to randomization:
One tablet by mouth (weight based dosing at 1.5 mg/kg and rounded to the closest tablet dose at either 60 mg, 100mg, or 150 mg tablet) once a day with food and a full glass of water (about 8 ounces)
100 mg twice daily with food and a full glass of water (about 8 ounces)
Time frame: From enrollment to the end of treatment at 4 weeks.
Assessing change in the relative abundance of tetracycline resistant bacteria in the gut microbiome following treatment.
Time frame: From enrollment to the end of treatment at 4 weeks.
Assessing change in the relative abundance of fungi/yeast in the gut microbiome following treatment.
Time frame: From enrollment to the end of treatment at 4 weeks.
Assesing change in inflammatory and non-inflammatory lesions.
Time frame: From enrollment to the end of treatment at 4 weeks.
Assessing the change in Alpha Diversity of the gut microbiome via Shannon Diversity
Time frame: From enrollment to the end of treatment at 4 weeks.
Change in investigator global assessment of acne
Time frame: From enrollment to the end of treatment at 4 weeks.
Assessing change in relative abundance of short chain fatty acid production genes upon gut microbiome analysis.
Time frame: From enrollment to the end of treatment at 8 weeks.
Assessing change in the relative abundance of the skin microbiome via Shannon Diversity.
Time frame: From enrollement to the end of treatment at 4 weeks.
Assessing change in the relative abundance of fungi/yeast in the skin microbiome.
Contact information is provided by the study sponsor or research team.
Integrative Skin Science and Research
Industry
The Effects of Sarecycline Versus Doxycycline on the Gut Microbiome and Skin Microbiome in Acne.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06447480
Acne Vulgaris, Acneiform Eruptions
Nice, Alpes-Maritimes, France
View Trial DetailsNCT06225570
Acne Vulgaris, Acneiform Eruptions
Charleston, South Carolina, United States
View Trial DetailsNCT07474883
Acne Vulgaris, Acneiform Eruptions
Ho Chi Minh City, Vietnam
View Trial DetailsNCT07056673
Acne Vulgaris, Acneiform Eruptions
Luoyang, Henan, China
View Trial Details